8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Jun 3, 2019 · 7y ago · Accession 0001171843-19-003763
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Jun 3, 2019
- Report date
- Jun 2, 2019
- Document
- f8k_060319.htm
- Size
- 4.1 MB